GPC3 and neoplasm: Therapeutic monoclonal antibody that recognizes an epitope in the C-terminal portion of GPC3 (524–563) (hGC33), which recognizes the C-terminal epitope of GPC3 (524–563), inhibits tumor growth in subcutaneous xenografts of HepG2 and Huh-7 in mice [9, 10].